Hepatoprotectors including antioxidant supplements(Vit E,silymarin,GSH,betaine,ect.)and others(essentiale,UDCA,tiopronin,Glycyrrhiza preparation,pentoxifylline,ect.)have been considered reasonable approaches to nonalcoholic fatty liver disease(NAFLD).However the evidence-based medicine shows that they can improve symptoms and decrease aminotransferases levels.There is no sufficient evidence to support their effect on the improvement of histological changes and the natural history of NAFLD.These kinds of medicines with 1 to 2 drugs being selected in one prescription are recommended to the patients with nonalcoholic steatohepatitis(NASH).Basic regimens for the treatment should be concomitant to enhance their efficacy.

The necessity and feasibility of antiviral therapy in patients with liver cirrhosis have caught much attention.By summarizing the rel-evant guidelines/consensus statements and evidence-based medicine data in recent years,the advances in indications,strategies,drug op-tions,and benefit/risk in antiviral therapy for hepatitis B virus (HBV)-and hepatitis C virus (HCV)-related cirrhosis are reviewed.The data reveal that for both HBV-and HCV-related cirrhosis,successful treatment may suppress viral replication,improve patients′conditions, delay disease progression,prolong survival,reduce complications,and create better conditions for surgical and minimally invasive operations for hepatocellular carcinoma.Because of the good safety of nucleos(t)ide analogues (NA),it is recommended that patients with HBV-related cirrhosis (including those in decompensation stage and with complications)should receive NA as soon as possible.As interferon may cause many adverse reactions,antiviral therapy for HCV-related cirrhosis becomes more difficult than that for HBV-related cirrhosis.Careful se-lection of indications is necessary.Standardization of the strategies for antiviral therapy is important in the treatment of liver cirrhosis.

The incidence of colorectal cancer( CRC)increases rapidly in recent years. The role of dietary structure in CRC pathogenesis has caught much attention. This review summarizes the relationship between dietary fiber intake and risk of CRC. Accumulating evidence reveals that up to 90% CRC can be prevented by improvement of dietary structure,and high fiber intake(10-35 g/d)decreases 10%-17% of risk of CRC. All kinds of dietary fiber have preventive effect. So far, dietary fiber intake in Chinese people does not reach the recommended level. Optimization of dietary structure,increase intake of whole grains,vegetable and fruit,addition of fiber to daily food are effective approaches for prevention of CRC.

In the present study, electron microscopic and cytochemical localization of succinic dehydrogenase (SDH) of the tumor-like growth tissue in the Tiger-head goldfish (Carassius aurtus) were attempted. The SDH was demonstrated according to the modified method described by Kerpel-Fronius and Hajos (1968). The main results are as follows:When the goldfish were twenty-months old, there was not only a highly active positive reaction of SDH on the periphery of jejune vesicle, but also on the mitochondria, cristae and cytoplasm membrane in the cells of the hyperplasitic tissue. At the same time, there were much crystal formation because cell disintegration. When the Tiger-head goldfish were ten and thirty-months old, the active reaction of SDH was not so strong as in the corresponding positions of cytodeme as When it was twenty-months old. The crystal formation were lesser than the others. But the control groups displayed the negative reaction of SDH in the corresponding positions.

Objective To investigate the prevalence of subclinical hepatic encephalopathy(SHE) in patients with cirrhosis. Methods One hundred and seventy five consecutive cirrhotic patients(mean age 53 years, range 27～72) without any overt clinical encephalopathy were screened for SHE using number connection test A(NCT A) and symbol digit test(SDT) with age corrected normal value, which have been developed in 356 persons without liver disease and are defined as the mean?2 standard deviation. Results Fifty patients(28.6%) were abnormal in both NCT A and SDT, 16(9.1%) were abnormal only in SDT and 34(19.4%) only in NCT A. Taken together, two tests diagnosed SHE in 100 patients(57.1%). The prevalence of SHE increased from 46.8% and 53.0% in Child Pugh grade A and B, to 76.6% in Child Pugh grade C. Conclusions SHE was found in 57.1% of cirrhotic patients without overt clinical encephalopathy, which was linked to the severity of liver cirrhosis.

Objective To assess the incidence of noctu rnal acid breakthrough(NAB) and its' relationship with Helicobacter pylori(H. pylori) infection in patients with duodenal ulcer. Methods Forty duodenal ulcer patients were randomly allocated in to five groups. Patients were treated by intravenous injection of omeprazole 40 mg twice daily(group 1), once daily(group 2), omeprazole 20 mg twice daily oral ly(group 3), omeprazole 20 mg once daily orally(group 4), and intravenous inject ion of cimetidine 600 mg twice daily (group 5) all for 5 days. Intragastric pH o ver 24 hours was consecutively recorded on the fifth day for each patient. Results The mean intragastric pH, median intragastric pH, nocturn al mean pH and nocturnal median pH in group 1(6.9?0.7,7.3?0.8,6.8?0.9,7.1? 0 .7) were significantly higher than those of group 2 (5.3?1.6,5.6?1.7,4.9?1. 5,4.3?1.7),group 4(4.8?0.7,4.8?1.0,4.7?0.8,4.5?0.8), and group 5(4.4?2.4 ,4.5?2.5,4.6?2.7,4.3?2.1), but not higher than group 3(6.2?0.7,6.3?0.8,6. 4?1.1,6.4?0.8). High intragastric pH was produced in all five groups. The frac tion time of pH below 4.0 in group 1(3.1%) and group 3(4.5%) were significantly fewer than that in the other three groups(group 2,27.8%; group 4, (32.4)%, and group 5,48.2%) respectively. NAB occurred in 1 patient from two omeprazole twice dai ly groups(6.3 %, group 1 and 3) and in 9 patients from two omeprazole once daily groups((56.3 %,) group 2 and 4,P

Objective To investigate the prevalence, clinical features and complications of gastrointestinal diverticula in Chinese people. Methods 551 patients with gastrointestinal diverticula were analyzed retrospectively. Results Among the 551 patients, 58.6% were over 60 years, and 11.6% were below 40 years. The incidence of esophageal diverticula, gastric diverticula, duodenal diverticula, jejunoileal diverticula and diverticula of the large intestine was 2.5%, 1.8%, 71.7% , 12.7% and 11.3% respectively. There were 6 and 11 patients, 9 and 6 patients, 69 and 271 patients, 1 and 24 patients, and 21 and 33 patients who were diagnosed by endoscopy and double contrast barium examination respectively. Among the 14 esophageal diverticula patients, the incidence of midesophageal diverticula (78.6%) was higher than that in pharyngoesophageal diverticula (11.2%). Among the 62 diverticula of the large intestine patients, the incidence of right side diverticula (56.5%) was higher than that of left side diverticula (38.7%). Almost esophageal diverticula and gastric diverticula were asymptomatic, while about half of the diverticula of the small and large intestine was symptomatic. The incidence of cholelithiasis and pancreatitis in patients with duodenal diverticula was 34.2% and 10.1% respectively. And the incidence of cholelithiasis and pancreatitis in descending segment was significantly higher than that in non descending segment ( P

Objective To assess the incidence and management of nocturnal acid breakthrough (NAB). Methods Forty patients with duodenal ulcer confirmed by gastroscopy were randomly divided into five groups, eight patients in each group. Patients were treated by the following strategies for a course of 5 days: group A (omeprazole 20 mg per day orally in the morning), group B (omeprazole 20 mg twice a day orally in the morning and at 4 p.m), group C (intravenous injection of omeprazole 40 mg twice a day in the morning and at 4 p.m), group D (omeprazole 20 mg per day orally in the morning plus ranitidine 150 mg at bed time) and group E (omeprazole 20 mg twice a day orally in the morming and at 4 p.m plus ranitidine 150 mg at bed time) respectively. Intragastric pH over 24 hours was recorded on the morning of the fifth day for each patient. Results In comparison with that in group A, intragastric pH was higher in the other four groups. The mean intragastric pH and mean nocturnal pH each in group B (6.2?0.7, 6.4?1.1), group C (6.9?0.7, 6.8?0.9), group D (6.0?0.7, 5.9?0.7) and group E (5.8?0.5, 6.1?0.5) were significantly higher than those in group A (4.8?0.7, 4.7?0.8, P

0.05). However in OAC group, there were significant differences between EM and IM(P0.05). Conclusions RAC and OAC triple therapy could eradicate H. pylori effectively. The efficacy of rabeprazole-based triple therapy was less affected by the CYP2C19 genotype. The eradication rates of H. pylori in PM and IM were higher than that in EM.

0.05).TNF-? mRNA of intervenient group was significantly increased than that of control group(P